Authorization of genetically modified maize DP910521 in the European Union

The European Parliament has examined the application for authorization of genetically modified maize DP910521 for food and feed. This decision comes in the context of a complex safety and environmental impact assessment. The process involves all EU citizens through potential effects on the food chain.

Context and objectives

The application was submitted by Corteva Agriscience in 2022, under Regulation (EC) No 1829/2003 on genetically modified food and feed. The objective is to authorize marketing in the EU of products derived from this maize, which produces the Cry1B.34 toxin and is resistant to the herbicide glufosinate.

Key measures

• Risk assessment for human and animal health
• Analysis of impact on biodiversity and environment
• Verification of compliance with EU standards for GMOs
• Examination of potential for genetic transfer to wild species
• Risk assessment associated with use of complementary herbicides

Timeline and implementation

The authorization process follows procedures established by Regulation (EU) No 182/2011. The Standing Committee on Plants, Animals, Food and Feed did not adopt an opinion in November 2024, and the Appeal Committee acted similarly in December 2024. The final decision belongs to the European Commission.

Impact for citizens and stakeholders

Farmers, food manufacturers and consumers are the main affected parties. Authorization could influence agricultural practices, food safety and the environment. EFSA (European Food Safety Authority) assessed the risks, but there are concerns about combined effects of Bt toxins and herbicide residues.